Certified by Founder Lodge
Tubulis GmbH
Germany - Munich, Bayern
START UP
1 Disclosed Funding Rounds $359,197,300
0 Participating Investments
-
Founded date
2012
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antib
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 16 ,2025 | Series C | $359,197,300 |
Seventure Partners
Wellington Management
Andera Partners
EQT Life Sciences
Nextech Invest
OCCIDENT
Bayern Kapital GmbH
Ascenta Capital
Frazier Life Sciences
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Pelage Pharmaceuticals | $120,000,000 | (Oct 16, 2025)
ego (YC W24) | $6,700,000 | (Oct 16, 2025)
Viven | $35,000,000 | (Oct 16, 2025)
Planyear | $12,000,000 | (Oct 16, 2025)
Aragorn AI | $4,300,000 | (Oct 16, 2025)
